Cell Line Development Market to Grow at a CAGR of 13% To 2023

MarketStudyReport.com adds “Cell Line Development Market Size By Product [Reagents & Media, Equipment (Incubator, Centrifuge, Bioreactor, Microscope), Accessories & Consumables], By Source [Mammalian, Non-Mammalian (Insects, Amphibians)], By Cell Line [Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line], By Application [Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research] Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Competitive Market Share & Forecast, 2016 – 2023" new report to its research database. The report spread across 149 pages with tables and figures in it.
Cell line development market is fragmented into bio-production, tissue engineering, research, toxic testing, regenerative medicine and drug discovery. As per the industry analysis by Global Market Insights Inc., as of today this market is valued at $2.8 billion USD in 2015 and is expected to grow by CAGR 13% from the year 2016 up to 2023. The key factors driving development in the market are augmented need for vaccines, proteins, therapeutic medicines and novel drugs. Increasing number of therapies and technological advancements is resulting in higher output and rising demand in global industry. Increase in the number of life threatening diseases like cancer resulting in increase in the demand for medicines and research contribute in boosting the forecast numbers. According to the WHO the numbers of cancer patients have increased thus fueling the market. Various components help in creation of cell lines like salt and media which provide nutrients to growing cells. Commonly used media in cell growth are DMEM media, RPMI media, MEM media, medium 199 and Hans F-10 media.
Request Sample Copy @ http://bit.ly/2h5L690
As per the regional analysis, the cell line development is the largest industry in the North America. The market size is expected to reach at USD $2.5 billion by the year 2023. The awareness amongst citizens about healthcare products has increased the need for biologics and cell therapies. Furthermore, countries like India and China from Asia Pacific region are likely to grow by 14% revenue during the projected period. The cell line Latin America market is expected to grow at CAGR of 13.3% revenue from USD $338.3 million.

Limited number of players rules the cell development market; Thermo Fisher Scientific Inc, GE, Lonza Group AG, Sigma Aldrich Corporation, Selexis SA, Corning Inc., WuXi AppTec Inc., European Collection of Cell Cultures (ECACC) and Sigma Aldrich Corporation.
Browse full table of contents and data tables @ http://bit.ly/2hmxHJc
Europe cell line development market size, by equipment, 2012 - 2023 (USD Million)
Europe cell line development market
The industry is competitive in nature marked by high industry rivalry are major market players. These companies offer wide range of product to maintain the leadership position. The accessories and consumable durable are registering highest growth of 16% through the forecast boosting the production of vaccines and antibodies. The patents for the epic drugs like Androgel, Lantus, Abilify are about to expire, in return US Food and Drug Administration have approved 15 proteins and therapeutic medicines. Top giants are determined to stay in the competitive market by capitalizing on available unexploited opportunities.
Enquiry before Buying @ http://bit.ly/2hmyzgS
To receive personalized assistance write to us @ sales@marketstudyreport.com with the report title in the subject line along with your questions or call us at +1 866-764-2150

Centralize market research purchases across your entire organization in one place.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management.

You can eliminate duplicate purchases and customize your content and license management.

This service is ideal for large organizations with multiple locations.

The Green Suite #4594,
Dover, DE 19901
United States

This release was published on openPR.